Key Details
Price
$11.89Annual ROE
1.24%Beta
-0.04Events Calendar
Next earnings date:
May 15, 2025Recent quarterly earnings:
Nov 14, 2024Recent annual earnings:
N/ANext ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
No data about analysts updates
Market Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Bellevue Life Sciences Acquisit doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Efficiency
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Institutional Ownership
Similar stocks
FAQ
- What is the primary business of Bellevue Life Sciences Acquisit?
- What is the ticker symbol for Bellevue Life Sciences Acquisit?
- Does Bellevue Life Sciences Acquisit pay dividends?
- What sector is Bellevue Life Sciences Acquisit in?
- What industry is Bellevue Life Sciences Acquisit in?
- What country is Bellevue Life Sciences Acquisit based in?
- When did Bellevue Life Sciences Acquisit go public?
- Is Bellevue Life Sciences Acquisit in the S&P 500?
- Is Bellevue Life Sciences Acquisit in the NASDAQ 100?
- Is Bellevue Life Sciences Acquisit in the Dow Jones?
- When was Bellevue Life Sciences Acquisit's last earnings report?
- When does Bellevue Life Sciences Acquisit report earnings?
What is the primary business of Bellevue Life Sciences Acquisit?
BLACU, or Bellevue Life Sciences Acquisit, is a special purpose acquisition company (SPAC) focused on investing in life sciences and healthcare companies. It aims to identify and merge with innovative firms to support their growth and development in the biotechnology and pharmaceutical sectors.
What is the ticker symbol for Bellevue Life Sciences Acquisit?
The ticker symbol for Bellevue Life Sciences Acquisit is NASDAQ:BLACU
Does Bellevue Life Sciences Acquisit pay dividends?
No, Bellevue Life Sciences Acquisit does not pay dividends
What sector is Bellevue Life Sciences Acquisit in?
Bellevue Life Sciences Acquisit is in the Financial Services sector
What industry is Bellevue Life Sciences Acquisit in?
Bellevue Life Sciences Acquisit is in the Shell Companies industry
What country is Bellevue Life Sciences Acquisit based in?
Bellevue Life Sciences Acquisit is headquartered in United States
When did Bellevue Life Sciences Acquisit go public?
Bellevue Life Sciences Acquisit's initial public offering (IPO) was on 10 February 2023
Is Bellevue Life Sciences Acquisit in the S&P 500?
No, Bellevue Life Sciences Acquisit is not included in the S&P 500 index
Is Bellevue Life Sciences Acquisit in the NASDAQ 100?
No, Bellevue Life Sciences Acquisit is not included in the NASDAQ 100 index
Is Bellevue Life Sciences Acquisit in the Dow Jones?
No, Bellevue Life Sciences Acquisit is not included in the Dow Jones index
When was Bellevue Life Sciences Acquisit's last earnings report?
Bellevue Life Sciences Acquisit's most recent earnings report was on 14 November 2024
When does Bellevue Life Sciences Acquisit report earnings?
The next expected earnings date for Bellevue Life Sciences Acquisit is 15 May 2025